Concepedia

Thomas H. Burkey

TH

15

Publications

947

Citations

15

H-Index

1991

Active since

Affiliations

University of Arizona(Current)

University of Illinois Chicago, Rockford campus

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Saint Louis University

Thomas H. Burkey is an author at University of Arizona specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

MedicinePharmacologyNeuropharmacologyMolecular PharmacologyPhysiologyNeuroscienceSignal TransductionHealthPharmacotherapyCell Signaling

Publications per year

1991–2004

15

Publications

15

SR141716A is an inverse agonist at the human cannabinoid CB1 receptor

Robert S Landsman, Thomas H. Burkey, Paul Consroe et al. · European Journal of Pharmacology · 1997 · 264 citations

Cannabis Use, Molecular Pharmacology, Biochemistry +7

6-isopropoxy-9-oxoxanthene-2-carboxylic acid (AH 6809), a human EP2 receptor antagonist

David F. Woodward, David J. Pepperl, Thomas H. Burkey et al. · Biochemical Pharmacology · 1995 · 106 citations

Medicinal Chemistry, Biochemistry, Medicine +6

Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain

Thomas H. Burkey, Raymond M. Quock, Paul Consroe et al. · European Journal of Pharmacology · 1997 · 93 citations

Cannabis Use, Relative Efficacies, Neurophysiology +11

Tumor necrosis factor α and interleukin-1β stimulate the expression of cyclooxygenase II but do not alter prostaglandin E2 receptor mRNA levels in cultured dorsal root ganglia cells

Jill C. Fehrenbacher, Thomas H. Burkey, Grant D. Nicol et al. · Pain · 2004 · 68 citations

Immune Regulation, Immunology, Cyclooxygenase Ii +19

Δ9-Tetrahydrocannabinol is a partial agonist of cannabinoid receptors in mouse brain

Thomas H. Burkey, Raymond M. Quock, Paul Consroe et al. · European Journal of Pharmacology · 1997 · 62 citations

Cannabis Use, Neurophysiology, Medicine +12

Rows per page

1–5 of 15